In Berlin, 26 August 2021, Eckert & Ziegler (ISIN DE0005659700, TecDAX), started the delivery of Technetium-99 generators in Brazil. The subsidiary Eckert & Ziegler Brasil Comercial Ltda. had recently received a license from the Brazilian health authority ANVISA as the first and only private company to import and distribute technetium generators. Two leading hospitals in the greater Sao Paulo area are among the first customers, and further orders have already been placed.

 Technetium generators are a core component for a nuclear medicine practice, yielding the isotope Tc-99m, the most widely used radioisotope in diagnostic procedure called SPECT, which is used to detect medical abnormalities. The generators need to be replaced regularly because the radioactive material in them has a short half-life. In Brazil, the SPECT market has a volume of about 100 million Euro per year. Eckert & Ziegler already supplies around 500 hospitals and clinics in this country with medical products and radioisotopes and now hopes to tap into the generator market. SPECT is often used to detect cardiac diseases, tumors, and metastases.

To read more please visit: Eckert & Ziegler Starts Technetium-99 Delivery in Brazil

Source: Wallstreet